Ovomet®: Joints

Ovomet®: Joints

Ovomet. Eggnovo
parallax background

Clinical studies



People suffering from osteoarthritis with moderate pain, runners and cross-fitters

Studies carried out on people suffering from osteoarthritis, and athletes, based on standardised methods approved by international bodies (WOMAC, DASH), achieving statistically very significant results.

  • Following 10 days of daily consumption of Ovomet®, positive effects were already perceivable, with an overall improvement of joints by 36%, revealing its high short-term effectiveness.
  • After 50 days of treatment, values of up to 68% were registered in the overall improvement of joints in runners, and 48% in people practising cross-fit

People suffering from osteoarthritis with severe pain

Study performed in an independent specialised clinic. The study group were: elderly patients diagnosed with osteoarthritis, taking Ovomet® 300mg for 50 days.

Study based on standardised methods, approved by international bodies (WOMAC) as well as on-site medical visits.

There was a notable reduction of almost 60% in stiffness and 49% in pain by the end of the treatment, considerably improving the quality of life of this demographic.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies